A breakthrough natural back pain relief program designed by wellness expert Emily Lark, the Back to Life Complete Healthy ...

Neuropathy No More is a digital wellness guide authored by natural health researcher Jodi Knapp and published by Blue Heron ...

About Nuvectis Pharma, Inc. Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...

D Molecular Therapeutics™, 4DMT™, Therapeutic Vector Evolution™, and the 4DMT logo are trademarks of 4DMT. All of our product candidates are in clinical or preclinical development and have not yet ...

In the aggregate, the new non-executive employees received options to purchase 214,000 shares of Annexon common stock. The options carry a ten-year term and an exercise price per share equal to $1.81, ...

The gross proceeds to the Company from the offering were approximately $2 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. The Company intends ...

A new campaign will portray the patient journey through the eyes of the virtual influencer, helping to educate and inspire her young fans to save a life through blood stem cell donation MINNEAPOLIS, ...

Why most generic weight loss, sexual health, skin care, and hair loss treatments fail to deliver lasting results Key insights into Strut Health’s weight loss programs, ED treatments, acne, and ...

Researchers at MIT’s Senseable City Lab and the University of Colorado Denver, in collaboration with the Clue app, have published the largest study of its kind examining the impact of air pollution on ...

SAN DIEGO, May 16, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage biotechnology company engaged in the discovery and development of ...

Trading in the Company’s SDRs on Nasdaq Stockholm commences on Monday, May 19, 2025, under the trading symbol (ticker) “ALVO SDB”. Settlement is expected to take place on May 21, 2025.